Chronic Obstructive Pulmonary Disease

The World Health Organisation (WHO) has described Chronic Obstructive Pulmonary Disorder (COPD) as a global epidemic; an estimated 210 million people have COPD worldwide and more than 3 million people died of the condition in 2005, which is equal to 5% of all deaths globally that year. Total deaths from COPD are projected to increase by more than 30% in the next 10 years without interventions to cut risks, particularly exposure to tobacco smoke.

Overview

Feature Articles

Latest Chronic Obstructive Pulmonary Disease News and Research

New insights into the link between respiratory infections and chronic lung diseases

New insights into the link between respiratory infections and chronic lung diseases

Accelerating tobacco decline could boost global life expectancy

Accelerating tobacco decline could boost global life expectancy

Study uncovers biological drivers of plasma proteins, offering new insights for disease biomarkers and drug discovery

Study uncovers biological drivers of plasma proteins, offering new insights for disease biomarkers and drug discovery

Research reveals key role of mucin modification in muco-obstructive diseases

Research reveals key role of mucin modification in muco-obstructive diseases

Genetic analysis challenges the idea that loneliness directly causes diseases

Genetic analysis challenges the idea that loneliness directly causes diseases

Loneliness may not be a direct cause of disease

Loneliness may not be a direct cause of disease

The Key Role of iPSC-Derived Microglia in Research and Drug Discovery

The Key Role of iPSC-Derived Microglia in Research and Drug Discovery

Study highlights physician and patient interest in climate-conscious healthcare

Study highlights physician and patient interest in climate-conscious healthcare

No difference in health outcomes between 24-hour and 15-hour oxygen therapy

No difference in health outcomes between 24-hour and 15-hour oxygen therapy

Shorter leukocyte telomere length and greater LTL attrition tied to cystic fibrosis severity

Shorter leukocyte telomere length and greater LTL attrition tied to cystic fibrosis severity

Preclinical blood test could predict severe respiratory conditions

Preclinical blood test could predict severe respiratory conditions

Voice changes detected by smartphone may signal COPD symptom flare-ups

Voice changes detected by smartphone may signal COPD symptom flare-ups

Study links air pollution and limited green spaces to higher respiratory hospitalization risk

Study links air pollution and limited green spaces to higher respiratory hospitalization risk

EBCare mask revolutionizes breath analysis with affordable, continuous monitoring

EBCare mask revolutionizes breath analysis with affordable, continuous monitoring

New smart mask monitors breath for real-time health analysis

New smart mask monitors breath for real-time health analysis

New study develops enhanced mortality prediction model for COPD patients

New study develops enhanced mortality prediction model for COPD patients

Widespread inhaler misuse in COPD patients: Need for training

Widespread inhaler misuse in COPD patients: Need for training

Novel drug-carrying molecule slips past the lung's natural defenses to cure disease

Novel drug-carrying molecule slips past the lung's natural defenses to cure disease

Improving COPD outcomes through enhanced inhaler education and technique

Improving COPD outcomes through enhanced inhaler education and technique

UC Davis Health experts urge wildfire preparedness action plans to support patients with respiratory diseases

UC Davis Health experts urge wildfire preparedness action plans to support patients with respiratory diseases

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.